Waltham, Massachusetts Wednesday, July 30, 2025, 11:00 Hrs [IST] ...

Avidity Biosciences completes enrolment in HARBOR phase 3 trial of delpacibart etedesiran to treat myotonic dystrophy type 1: San Diego Wednesday, July 30, 2025, 10:00 Hrs [IST] A ...

Peethaambaran Kunnathoor, Chennai Wednesday, July 30, 2025, 08:00 Hrs [IST] ...

Govt. Schemes helped growth of medical devices exports to 88% in six years: Centre: Gireesh Babu, New Delhi Wednesday, July 30, 2025, 08:00 Hrs [IST] The Schemes supporting develo ...

A culture of quality excipients has ushered in as the pharmaceutical industry advances towards manufacturing super and complex generics which requires high precision levels of process controls, Good ...

DGTR initiates anti-dumping probe on imports of “Bromo OTBN” from China: Shardul Nautiyal, Mumbai Wednesday, July 30, 2025, 08:00 Hrs [IST] Aimed at safeguarding domestic indu ...

Indian nutraceutical companies grapple with a maze of global regulatory challenges: Nandita Vijayasimha, Bengaluru Wednesday, July 30, 2025, 08:00 Hrs [IST] Indian nutraceutical c ...

China NMPA accepts for review Bayer’s NDA for sevabertinib to treat adult patients with advanced non-small cell lung cancer NSCLC: Berlin Tuesday, July 29, 2025, 13:00 Hrs [IST] ...

Elpis Biopharma inks MoU with National Cancer Centre Singapore to conduct translational cell therapy research in Singapore: Singapore Tuesday, July 29, 2025, 17:00 Hrs [IST] Elpis ...

Akeso announces China NMPA accepts sNDA for ivonescimab in combo with chemotherapy to treat advanced squamous NSCLC: Honk Kong Tuesday, July 29, 2025, 16:00 Hrs [IST] Akeso, Inc., ...

BPL Medical Technologies chief notes inking India-UK FTA to propel growth: Our Bureau, Bengaluru Tuesday, July 29, 2025, 15:30 Hrs [IST] BPL Medical Technologies managing director ...

Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat: New Taipei City Tuesday, July 29, 2025, 14:00 Hrs [I ...